Semaglutide and effective weight control

Lancet. 2021 Mar 13;397(10278):942-943. doi: 10.1016/S0140-6736(21)00377-9. Epub 2021 Mar 2.

Authors

Roberto Latini¹, Lidia Staszewsky²

Affiliations

¹ Department of Cardiovascular Medicine, Mario Negri Institute of Pharmacological Research IRCCS, 20156 Milan, Italy. Electronic address: roberto.latini@marionegri.it.
² Department of Cardiovascular Medicine, Mario Negri Institute of Pharmacological Research IRCCS, 20156 Milan, Italy.

PMID: 33667415
DOI: 10.1016/S0140-6736(21)00377-9

No abstract available

Publication types

Comment

MeSH terms

Adult
Diabetes Mellitus, Type 2* / drug therapy
Double-Blind Method
Glucagon-Like Peptides
Humans
Obesity / drug therapy
Obesity / prevention & control
Overweight

Substances

semaglutide
Glucagon-Like Peptides